286
Participants
Start Date
October 2, 2013
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
Docetaxel and capecitabine and oxaliplatin
Docetaxel 60 mg/m² IV Day 1 Capecitabine 800 mg/m² bid (Day 1-Day 14) Oxaliplatin 100 mg/m² IV Day 1
capecitabine and oxaliplatin
Capecitabine 1,000 mg/m² bid(D1-14) Oxaliplatin 130 mg/m² IV Day 1
RECRUITING
Asan Medical Center, Seoul
Lead Sponsor
Seoul National University Bundang Hospital
OTHER
Severance Hospital
OTHER
Inha University Hospital
OTHER
Hallym University Medical Center
OTHER
Asan Medical Center
OTHER